24 results on '"Rao H"'
Search Results
2. The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
3. Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance
4. p21-Associated Kinase 4 (PAK4) Addiction in Multiple Myeloma: A Potential Therapeutic Application with Enhanced Activity in FGFR3 Expressing Myeloma
5. Defining Fundamental B Cell-Subset Dysfunction in Myeloma
6. Evaluating the Efficacy and Toxicity of Two Lenalidomide Dose Regimens for the Treatment of Older Relapsed Multiple Myeloma Patients with Co-Morbidities: A Multi-Site Study at the Veteran's Administration Hospitals
7. IL-17A-Mediated Notch Signaling in Multiple Myeloma
8. Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target
9. Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma
10. Sp1 Inhibition Affects Cell Growth and Survival In Waldenstrom’s Macroglobulinemia Through a MYD88-Independent Pathway
11. Induction of T Cell Immunity Using a Multipeptide Cocktail Containing XBP1, CD138 and CS1 Peptides in Smoldering Multiple Myeloma
12. Reprogramming Aberrant B Cell-Subsets to Improve Immune Function in Multiple Myeloma
13. Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma
14. Targeting Sp1 Transactivation In Waldenstrom's Macroglobulinemia: a Novel Therapeutic Option
15. Perifosine Affects Phenotype and Function of Human Myeloid Dendritic Cells
16. Interleukin-17 and TH17 Pathway Supports Waldenstrom's Macroglobulinemia Cell-Growth: Potential Therapeutic Implications
17. Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities
18. Lack of Response to Vaccination in MGUS and Stable Myeloma.
19. Myeloma Microenvironment Controls T Regulatory Cell Activity: Potential Target for Therapeutic Interventions.
20. Physical and Functional Association of the MRN Complex with Human Telomerase in Multiple Myeloma.
21. Dysfunctional T regulatory cells in multiple myeloma
22. Proteasome Inhibitor Does Not Affect the Function of Human Immune Systems: Effects on Dendritic Cells, T Lymphocytes and NK Cells.
23. Novel Model To Evaluate Changes in Gene Expression Profile of Myeloma Cells In Vivo Following Interaction with Human BM Microenvironment.
24. Dysfunctional T Regulatory Cells in Myeloma: Molecular Mechanisms of Dysregulation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.